Hanmi reveals total 23 pipelines consisting of 14 biologics and 9 synthesized drugs
Hanmi Pharm(CEO Sae-Chang Kwon & Jong-Soo Woo) revealed the development status(hereinafter referring to pipeline) of 23 new drugs which are currently being developed now in 2017.
The company explained the purpose of the update is to exercise ‘trust management,’ the company’s goal, and to create ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
